Skip to main content
. 2010 Dec 29:26–455. doi: 10.1016/B978-0-443-07151-5.50005-6

Table 3.58.

Key considerations in dental management in G6PD deficiency (see text)

Management modifications* Comments/possible complications
Risk assessment 1 Avoid oxidant drugs

Appropriate dental care 2 Avoid oxidant drugs

Pain and anxiety control
 – Local anaesthesia 1 Avoid prilocaine
 – Conscious sedation 1
 – General anaesthesia 3/4

Patient access and positioning
 – Access to dental office 0
 – Timing of treatment 0
 – Patient positioning 0

Treatment modification
 – Oral surgery 0
 – Implantology 0
 – Conservative/Endodontics 0
 – Fixed prosthetics 0
 – Removable prosthetics 0
 – Non-surgical periodontology 0
 – Surgical periodontology 0

Hazardous and contraindicated drugs 2 Avoid aspirin, acetaminophen, sulphonamides and topical toluidine blue
*

0 = No special considerations. 1 = Caution advised. 2 = Specialised medical advice recommended in some cases. 3 = Specialised medical advice mandatory. 4 = Only to be performed in hospital environment. 5 = Should be avoided.